The Founder's Guide to

Ulixes Capital Partners

Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.

Explore our founder-friendly guide and choose if you'd like to be connected.
We'll either provide a warm intro or provide you with more suitable alternatives.
Once you're put in touch, we'll provide you with helpful advice. It's 100% free.

Overview

Ulixes Capital Partners (UCP) is a venture capital investment holding company established in 2019 and headquartered in Italy. The firm is dedicated to supporting founders in the earliest stages of company development, primarily focusing on pre-seed and seed investments. UCP has quickly gained a reputation for its commitment to investing in validated technology, targeting companies that are either already in the market or poised to enter it. With a portfolio that currently includes 11 companies, UCP has positioned itself as a key player in the European venture capital landscape.

The firm’s leadership is composed of experienced professionals who understand the unique challenges faced by early-stage startups. UCP's investment strategy is characterized by a hands-on approach, providing not only capital but also strategic guidance to help founders navigate the complexities of building a successful business. The firm primarily invests in sectors such as SaaS, healthcare, edtech, food-agtech, and consumer products, reflecting a diverse range of interests that align with current market trends.

Since its inception, UCP has focused on Italian founders, both within Italy and abroad, fostering a strong network of entrepreneurs and innovators. This geographic focus allows UCP to leverage local insights while also tapping into broader European opportunities. The firm’s commitment to early-stage investments in validated technology sectors distinguishes it from other venture capital firms, making it an attractive partner for startups seeking initial funding and support.

Learn More

Frequently Asked Questions

What stages does Ulixes Capital Partners invest in?

Ulixes Capital Partners primarily invests in the pre-seed and seed stages of company development. This focus allows them to support founders at the earliest phases of their entrepreneurial journey, providing essential capital and guidance.

How do I pitch Ulixes Capital Partners?

Founders interested in pitching to Ulixes Capital Partners can reach out via email at info@ulixescapital.com. It is advisable to prepare a clear and concise pitch that outlines the business model, market opportunity, and the technology being developed.

What sectors does Ulixes Capital Partners focus on?

UCP targets a variety of sectors including SaaS, healthcare, edtech, food-agtech, and consumer products. Their investment strategy emphasizes validated technology that is either on the market or about to launch.

What is Ulixes Capital Partners' typical check size?

The typical check size for investments made by Ulixes Capital Partners ranges from €150,000 to €300,000. This range is designed to provide substantial support for early-stage startups.

Where does Ulixes Capital Partners invest geographically?

UCP primarily invests in Italian founders, both within Italy and abroad. This geographic focus allows them to leverage local insights while also tapping into broader European opportunities.

What is the application process for Ulixes Capital Partners?

The application process involves reaching out via email at info@ulixescapital.com. Founders should prepare a detailed pitch that highlights their business model and technology.

What portfolio support does Ulixes Capital Partners provide?

While specific details on portfolio support are not mentioned, UCP's investment strategy includes providing strategic guidance to help founders navigate the complexities of building a successful business.

All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.